MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired ...
Chronic kidney disease tied to brain atrophy, potential Alzheimer's risk
Nearly 10% of people live with chronic kidney disease—in other words, their kidneys can't adequately filter waste from their ...
Nasdaq3d
INNOVATE Corp. Announces FDA Approval of MediBeacon® Transdermal GFR System for Kidney Function Assessment
INNOVATE Corp. announced the FDA approval of the MediBeacon® Transdermal GFR System (TGFR), a groundbreaking ... individuals affected by Chronic Kidney Disease (CKD), the approval is seen as ...
rheumatologyadvisor3d
Children With ANCA-Associated Vasculitis at High Risk for Long-Term Renal Damage
Children with AAV and kidney disease face increased risks for long-term renal damage at 1 year, despite the majority achieving inactive renal disease by this time.
Yahoo Finance3d
MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function
Transdermal GFR System (TGFR) is a first-in-kind product ... renal function More than 800 million people have Chronic Kidney Disease (CKD), one of the world’s leading causes of mortality ...
Yahoo Finance3d
MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function More than 800 million people have Chronic ...
Yahoo Finance3d
MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function
The transdermal GFR (tGFR) methodology has been designed to be effective across the adult population without input of age, weight, sex, gender, race, or ethnicity. More than 800 million people have ...